Literature DB >> 14635822

Clinical pharmacokinetics of morphine.

Ralph A Lugo1, Steven E Kern.   

Abstract

Morphine, the most widely used mu-opioid analgesic for acute and chronic pain, is the standard against which new analgesics are measured. A thorough understanding of the pharmacokinetics of morphine is required in order to safely and effectively use this analgesic in a wide variety of patients with different levels of organ function. A MEDLINE search was conducted to identify literature published between 1966 and January 2002 relevant to the pharmacokinetics of morphine. These publications were reviewed and the literature summarized regarding unique and clinically important elements of morphine disposition relative to its parenteral administration (including intravenous, intramuscular, subcutaneous, epidural and intrathecal administration), absorption profile (immediate release, controlled release, and sublingual/buccal, and rectal administration), distribution, and its metabolism/excretion. Special populations, including infants, elderly, and those with renal/liver failure, have a unique morphine pharmacokinetic profile that must be taken into account in order to maximize analgesic efficacy and reduce the risk of adverse events.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14635822     DOI: 10.1080/j354v16n04_02

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  26 in total

1.  Skin pretreatment with an Er:YAG laser promotes the transdermal delivery of three narcotic analgesics.

Authors:  Woan-Ruoh Lee; Shing-Chuan Shen; Chia-Lang Fang; Ching-Ru Liu; Jia-You Fang
Journal:  Lasers Med Sci       Date:  2007-03-03       Impact factor: 3.161

2.  PolyMorphine: an innovative biodegradable polymer drug for extended pain relief.

Authors:  Roselin Rosario-Meléndez; Carolyn L Harris; Roberto Delgado-Rivera; Lei Yu; Kathryn E Uhrich
Journal:  J Control Release       Date:  2012-08-03       Impact factor: 9.776

3.  The dosing frequency of sustained-release opioids and the prevalence of end-of-dose failure in cancer pain control: a Korean multicenter study.

Authors:  Do-Yeun Kim; Hong-Suk Song; Jin-Seok Ahn; Baek-Yeol Ryoo; Dong-Bok Shin; Chang-Yeol Yim; Si-Young Kim
Journal:  Support Care Cancer       Date:  2010-03-07       Impact factor: 3.603

4.  Thermal sensitivity across ages and during chronic fentanyl administration in rats.

Authors:  Jeremiah D Mitzelfelt; Christy S Carter; Drake Morgan
Journal:  Psychopharmacology (Berl)       Date:  2013-07-31       Impact factor: 4.530

5.  Effects of morphine on thermal sensitivity in adult and aged rats.

Authors:  Drake Morgan; Jeremiah D Mitzelfelt; Lorraine M Koerper; Christy S Carter
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-21       Impact factor: 6.053

6.  Sweet taste pleasantness is modulated by morphine and naltrexone.

Authors:  Marie Eikemo; Guro E Løseth; Tom Johnstone; Johannes Gjerstad; Frode Willoch; Siri Leknes
Journal:  Psychopharmacology (Berl)       Date:  2016-08-18       Impact factor: 4.530

Review 7.  [Cancer pain therapy].

Authors:  F Nauck
Journal:  Urologe A       Date:  2009-10       Impact factor: 0.639

Review 8.  Pediatric Oncology: Managing Pain at the End of Life.

Authors:  Jennifer M Snaman; Justin N Baker; Jennifer H Ehrentraut; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

9.  Postoperative analgesia with minidose intrathecal morphine for bipolar hip prosthesis in extremely elderly patients.

Authors:  Kazunori Yamashita; Makoto Fukusaki; Yuko Ando; Takahiro Tanabe; Yoshiaki Terao; Koji Sumikawa
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

10.  Absorption, metabolism, and excretion of 14C-labeled tapentadol HCl in healthy male subjects.

Authors:  Rolf Terlinden; Joachim Ossig; Frank Fliegert; Claudia Lange; Karin Göhler
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Jul-Sep       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.